Title:
ORAL AGENT
Document Type and Number:
WIPO Patent Application WO/2018/101269
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide: an oral agent including two or more oily components, wherein the oral agent is capable of exhibiting a good balance between dispersibility and stability; and a method for producing a soft capsule agent. The present invention is: an oral agent including component (A): an n-3 fatty acid such as docosahexaenoic acid, component (B): a crystalline oily component such as lutein, capsanthin, zeaxanthin, β-cryptoxanthin, and astaxanthin, and component (C): a glycerin fatty acid ester or polyglycerin fatty acid ester having an HLB of 5 or lower; and a method for producing a soft capsule agent.
More Like This:
Inventors:
KANESHIMA DAISUKE (JP)
SUGAFUJI TOSHIHIRO (JP)
MATSUNO AYUMI (JP)
YAMAGA HIROAKI (JP)
ORIHARA YOICHI (JP)
SUGAFUJI TOSHIHIRO (JP)
MATSUNO AYUMI (JP)
YAMAGA HIROAKI (JP)
ORIHARA YOICHI (JP)
Application Number:
PCT/JP2017/042649
Publication Date:
June 07, 2018
Filing Date:
November 28, 2017
Export Citation:
Assignee:
LION CORP (JP)
International Classes:
A61K31/045; A61K9/48; A61K31/122; A61K31/202; A61K47/14; A61K47/34; A61P3/00
Domestic Patent References:
| WO2014051116A1 | 2014-04-03 | |||
| WO2014051115A1 | 2014-04-03 |
Foreign References:
| JP2015034161A | 2015-02-19 | |||
| JP2009511052A | 2009-03-19 | |||
| JP2013126974A | 2013-06-27 | |||
| JP2015155384A | 2015-08-27 |
Other References:
ARNAL, E. ET AL.: "Lutein and docosahexaenoic acid prevent cortex lipid peroxidation in streptozotocin-induced diabetic rat cerebral cortex", NEUROSCIENCE, vol. 166, no. 1, 22 January 2010 (2010-01-22), pages 271 - 278, XP026871132, ISSN: 0306-4522
Attorney, Agent or Firm:
SAKAI INTERNATIONAL PATENT OFFICE (JP)
Download PDF:
Previous Patent: THREE-DIMENSIONAL MEASUREMENT DEVICE
Next Patent: COLD STORAGE SOLUTION AND STORAGE METHOD FOR MOUSE SPERM
Next Patent: COLD STORAGE SOLUTION AND STORAGE METHOD FOR MOUSE SPERM